Our favorable outlook for the biotechnology industry remains intact for 2012 and is based on several key drivers
2009: Positive Perspectives for Biotechnology
January 7, 2009 By 4 Comments
After a brief bout of euphoria during the early portion of the decade, the biotechnology industry, as measured by the Amex Biotech Index (BTK), was shunned by investors for the better part of the 1990’s. The BTK, which was established with a benchmark value of 200 on October 18, 1991, declined by 50% to nearly [...]
Follow MD Becker Partners